In such cases, immunohistochemical analysis using markers such as HMB-45 (positive in 85–90% of melanomas), S-100 (95–100% sensitivity), and MART-1 (75–80% specificity) becomes indispensable for accurate diagnosis and appropriate management [23,26]. This evidence concerns the gene PMEL and melanoma.